Salute e Benessere

Kolmar Korea Selected for Government-Led 'AI Factory' Initiative -- Driving…

The Ministry of Trade, Industry and Resources (MOTIR) is South Korea's central government agency overseeing industrial technology, R&D, commerce, and trade. Under its national vision of becoming the "World's Leading Manufacturing Power by 2030," the ministry launched the AI Factory M.AX (AI Transformation) Alliance, selecting leading companies from each sector to drive AI innovation in manufacturing. Kolmar Korea was chosen as the sole cosmetics company to lead the initiative…
PR Newswire
27/10/2025

Building a Greener Future: 138th Canton Fair Marks the Rise of Eco-Friendly…

Another exhibitor, led by its general manager, has participated in over 40 editions of the fair and maintains a presence in more than 50 countries. The company continues to view the Canton Fair as a strategic gateway to global markets. Its featured offerings include wall panels made from medical-grade PVC and bamboo fiber, designed for moisture resistance, mold prevention, and easy installation. The exhibitor also introduced WPC outdoor flooring, combining the natural appearance of wood with the…
PR Newswire
27/10/2025

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability…

Click here to view the custom infographic of the Oncotelic Therapeutics editorial. Clickhere to view the custom infographic of the Oncotelic Therapeutics editorial. The Global Shift Toward Smarter Drug Delivery The pharmaceutical industry is entering an inflection point driven by therecognition that highly potent cancer drugs are only as effective as their ability to reach tumors with sufficient concentration. Many promising oncology drugs fail not because the therapy lacks...
PR Newswire
27/10/2025

Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer

Dr Tayton-Martin brings broad experience of biotech company building, fund-raising, M&A, business development and operations with a strong track record of strategic partnership dealsHer more than 30 years of experience include leadership roles in the UK and US, from early research through to product approval in cancer immunotherapy, making her the ideal candidate to lead the next stage of execution of Evaxion’s strategy Birgitte Rønø, who has served as interim Chief Executive...
Nasdaq GlobeNewswire
27/10/2025

KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in…

The new plant, located on the hospital’s Riyadh campus, will produce CAR T-cell and stem-cell therapies, treatments that re-engineer a patient’s own cells to fight cancer or repair damaged tissue. Spanning more than 5,000 square meters, the facility is designed around 16 modular clean-room clusters that can expand or adapt as new therapeutic technologies evolve.Officials said the complex marks a milestone in Saudi Arabia’s biotechnology ambitions, bringing precision medicine and advanced...
Nasdaq GlobeNewswire
27/10/2025

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on…

MAINZ, Germany, October 27, 2025 (GLOBE NEWSWIRE)--BioNTech SE(Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2025 on Monday, November 3, 2025. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EST (2:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update.To access the live conference call via telephone, please...
Nasdaq GlobeNewswire
27/10/2025

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on…

MAINZ, Germany, October 27, 2025 (GLOBE NEWSWIRE)--BioNTech SE(Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2025 on Monday, November 3, 2025. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EST (2:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update.To access the live conference call via telephone, please...
Nasdaq GlobeNewswire
27/10/2025

Immatics Appoints Amie Krause as Chief People Officer

Houston , Texas and Tuebingen, Germany, October 27, 2025–Immatics N.V.(NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, today announced the appointment of Amie Krause as Chief People Officer (“CPO”) effective October 27, 2025. Ms. Krause brings more than 20 years of experience in shaping culture, leading organizational growth and aligning talent with business strategy, including across global...
Nasdaq GlobeNewswire
27/10/2025

Antibody-Drug Conjugates Market to Surge to US $30.42 Billion by 2033, Fueled by…

Download PDF Brochure: https://www.datamintelligence.com/download-sample/antibody-drug-conjugates-market Download PDF Brochure:https://www.datamintelligence.com/download-sample/antibody-drug-conjugates-market Browse in-depth TOC on "Antibody-Drug Conjugates Market"70 – Tables 66 – Figures 195 – Pages Market Outlook: Accelerated Growth in Oncology's Most Promising Segment In 2024, the Antibody-Drug Conjugates market crossed the US$11 billionthreshold, propelled by...
PR Newswire
27/10/2025

Fairland COP7 R290 ATW HeatPump - The Future of AI HeatPump

First COP 7.0 AI Heat Pump FirstCOP 7.0AI Heat Pump The Fairland R290 ATW Heat Pump is the first on the market to achieve aCOP of 7.0, a breakthrough enabled by innovative structural design andFairland's AI Inverter technology. With dual A+++ level performance, it redefines energy efficiency, delivering around 40% higher efficiency than average systems. Its preciseAI control optimizesR290 refrigerant use, ensuring safe, efficient operation and every component works in...
PR Newswire
27/10/2025

Amphista Therapeutics’ successful degradation of a key cancer target, BRD9, via…

The publication reports the highly selective, DCAF16 E3 enabled degradation of BRD9in vivousing Amphista’s proprietary, next generation Targeted Glue™ medicinal chemistry technologyAmphista’s scientists prospectively and rationally designed therapeutic molecules with a novel mechanism, intrinsic oral bioavailability and favourable drug-like propertiesAmphista’s proprietary Targeted Glues™ offer an exciting new strategy for targeted protein degradation in acute myeloid leukaemia and...
Nasdaq GlobeNewswire
27/10/2025

NHS-licensed healthcare platform Evaro partners with period tracking app Clue in…

Partnership bridges the gap between period tracking and contraception access as nearly half of UK women face barriers to contraception care Clue , the #1 women-led period and cycle tracker trusted by over 100 million worldwide, to provide seamless access to NHS-funded contraception directly through Clue's app.This marks the first time a major cycle-tracking platform has integrated prescription healthcare services in the UK, creating a critical solution as the country grapples with an...
Nasdaq GlobeNewswire
27/10/2025

Implantica presents the third quarter 2025 on October 31 at 15:00 CET

If you wish to participate via webcast, please use the following link: If you wish to participate via webcast, please use the following link: If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the conference. Speakers: For further information, please contact: Nicole Pehrsson, Investor Relations Telephone (CH): +41 43 505 20 57nicole.pehrsson@implantica.com ...
PR Newswire
27/10/2025

Inside information: Bioretec is revising its financial targets, deems that the…

The Company is currently in the process of assessing and updating its overall commercialization strategy and pipeline and will be providing an update by the end of 2025. However, in the course of its assessment, the Board of Directors of Bioretec has now concluded that the financial targets published on 4 October 2024 are unattainable and will likely not be met. In particular, the Board of Directors of Bioretec deems that the target of reaching net sales of EUR 65 million by the end of the year…
PR Newswire
27/10/2025

Stockholm hospitals unify all imaging in Sectra's cloud service to boost…

"By consolidating all imaging into a unified system across all hospitals and specialties, our staff can efficiently access and share images regardless of location. This enables streamlined region-wide workflows, supporting the management of referrals, examinations, and diagnoses—ultimately contributing to improved patient safety," says Mikael Ohrling, Director of Healthcare, Region Stockholm. "By consolidating all imaging into a unified system across all hospitals and specialties…
PR Newswire
27/10/2025

Cipla's flagship respiratory initiative Breathefree broadens its footprint in…

Cipla is launching the first phase of Breathefree UAE with a localized, bilingual website and educational videos to guide patients on the correct use of its respiratory devices. The platform will provide tailored resources, device training, and a scalable ecosystem that will gradually expand to include adherence tools such as reminder alerts and digital educators. Cipla is launching the first phase of Breathefree UAE with a localized, bilingual website and educational videos to guide patients...
PR Newswire
27/10/2025

Klea Holding strengthens its presence in Dubai with its first strategic real…

Paris, 27 October 2025 KLEA HOLDING (FR0013481835 – ALKLH), a group specialising in the acquisition, development and digitalisation of companies in various sectors, announces its first real estate investment in Dubai as part of a prestigious office property development project, Lumena Alta, developed by Omniyat, one of the emirate's most reputable developers…
Actusnews Wire
27/10/2025

World's First Multi-Omics LLM, Promising to Decode the Language of Human Biology…

PanOmiQ’s foundational model trained on multi-Omics data breakthrough FPGA-powered deployment addresses data sovereignty challenge, ultrafast AI-driven multi-omics analysis on premises, redefining speed and accuracy in precision medicine ‘The BioIntelligence™’powers its flagship platform, PanOmiQ™, which will be showcased at the Global Health Exhibition – Riyadh, offering a new paradigm where biology is not just measured, but truly understood.The central failure of modern medicine is...
Nasdaq GlobeNewswire
27/10/2025

Health Canada Grants Authorization for Leqembi® (lecanemab)

The approval of Leqembi is based on the large global Phase 3 Clarity AD study. In the Clarity AD study, Leqembi met its primary endpoint and all key secondary endpoints with statistically significant results.2,3 Leqembi has been issued market authorization in Canada with conditions, pending the results of trials to verify its clinical benefit. Eisai plans to submit clinical assessment data captured from participants in real-world clinical practice. The approval of Leqembi is based on the…
PR Newswire
27/10/2025

138th Canton Fair Showcases Practical Aesthetics in Home and Garden Innovation

Another exhibitor is turning agricultural by-products into valuable decorative items. Through circular design principles, discarded materials such as tea and mulberry branches are repurposed into high-end crafts, achieving full reuse of raw materials and significantly reducing agricultural waste. Among its featured products, the Tea Branch Art Frame Series and Color Wood Inlay Ornaments have attracted attention for their fusion of natural textures, Chinese design motifs, and Western decorative…
PR Newswire
27/10/2025

New Global Coalition Launches to Address the Hidden Threat of RSV in Adults

With core members including leading advocacy organizations the International Federation on Ageing (IFA) and the Global Allergy and Airways Patient Platform (GAAPP), alongside GSK, and with the European Scientific Working Group on Influenza (ESWI) providing scientific oversight, the RSV Alliance seeks to drive education, advocacy, and collaboration to improve prevention and care for those most vulnerable to RSV.RSV is often thought to primarily affect infants and young children, but it also...
Nasdaq GlobeNewswire
26/10/2025

Novartis agrees to acquire Avidity Biosciences, an innovator in RNA…

Ad hoc announcement pursuant to Art. 53 LR Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseasesAdvances the Novartis xRNA strategy by adding a scientifically robust, muscle-directed, Antibody Oligonucleotide Conjugates (AOCs™) platform and first-in-disease pipelineExpected to unlock multi-billion-dollar opportunities with planned product launches before 2030 Raises expected 2024-2029 sales CAGR...
Nasdaq GlobeNewswire
26/10/2025

Real-World Data Presented at TCT 2025 Demonstrates the EggNest™ Complete…

Teamwide protection was also demonstrated: nurses and technologists recorded average exposures of just 0.03 mRem per case, further confirming the EggNest System's ability to safeguard the entire room. Teamwide protection was also demonstrated: nurses and technologists recorded average exposures of just 0.03 mRem per case, further confirming the EggNest System's ability to safeguard the entire room. "Having a radiation protection system that consistently protects my entire team as well as…
PR Newswire
26/10/2025

mediCAD® 8 Revolutionizes Orthopedic and Trauma Planning with Intelligent AI…

At the heart of the new release lies mediCAD AI, a framework that uses advanced algorithms to automatically recognize anatomical landmarks and interpret medical images with remarkable precision. The system detects key reference points across the hip, knee, and lower limb, supporting surgeons with data-driven accuracy from the first step of the planning process. Comparative studies show that landmark detection in mediCAD® 8 achieves an average deviation of less than two millimeters, ensuring...
Nasdaq GlobeNewswire
26/10/2025
Altri  Comunicati